INTRODUCTION
West Nile virus (WNV) was introduced into the New York City area in 1999, producing an equine and avian epizootic and 68 cases of human disease.1 Surveillance data from 1999 do not exist for much of New York State, but all evidence for intense transmission (the presence of human cases and/or detection of infection in mosquito pools) occurred in the downstate region of New York City, Long Island, and in Westchester and Rockland counties, immediately to the north of New York City. In 2000 and 2001, although transmission was documented broadly throughout the state, most evidence for intense transmission and all human cases occurred within the initial downstate epicenter2 of WNV activity. During the 2002 and 2003 transmission seasons, intense transmission again occurred in the downstate epicenter, but was also detected in upstate and western New York, where human cases occurred for the first time (http://www.health.state.ny.us/nysdoh/westnile/update/2002/today2002.gif and http://www.health.state.ny.us/nysdoh/westnile/update/2003/wnv_map.gif).
The RNA viruses are notable for their high mutation rates and consequent potential for rapid evolution.3 Nonetheless, arboviruses possess remarkable genetic and antigenic stability in nature.4–6 West Nile virus apparently has undergone limited evolution in the years during which it has been observed in the United States. Strains collected from New York in 2000 were relatively homogeneous with genetic distances of 0.003 or less.7 Strains collected in Texas during the year 2002 transmission season were similarly homogeneous, but two distinct genotypes were detected.8 Most studies of WNV evolution since its introduction into the Americas have analyzed a relatively small portion of the WNV genome, focusing on the envelope (E) glycoprotein due to its functional significance in viral attachment to host cell receptors and subsequent fusion with the host cell membrane, and because it contains major immunodominant epitopes.9–12 Sequencing studies of the entire WNV genome included strains collected worldwide, and included a relatively small number of strains collected relatively early in the course of the North American epidemic.13 No published study of WNV since its introduction into the Americas has included comparative phenotypic studies of viral replication in vitro or in vivo in mosquitoes.
Accordingly, we collected WNV strains from New York State during the years 2000–2003 and defined their genotype based on the complete coding region of the E protein to determine whether changes in viral genetics accompanied the observed changes in WNV epidemiology in 2002 and 2003 compared with 2000 and 2001. In addition, fragments of the NS5 and 3′ untranslated region (3′UTR) of strains collected during the 2002 and 2003 transmission seasons were analyzed to determine whether estimates of nucleotide and amino acid diversity may be dependent on the region of the genome studied. Finally, it was determined whether differences in viral genotype were associated with either in vitro or in vivo replicative efficiency. The resulting data allow us to more fully characterize WNV evolution since its introduction into North America, and to ascertain whether this agent is adapting to local transmission cycles.
MATERIALS AND METHODS
Virus strains.
Infectious virus or viral RNA was isolated from selected pools of infected mosquitoes or vertebrate tissues. Mosquito pools and vertebrate tissues were submitted to the New York State Arbovirus Laboratories during the years 2000–2003 and screened for infection as described.14 Viral RNA was isolated directly from infected materials using RNEasy spin columns (Qiagen, Inc., Valencia, CA) as described elsewhere7 whenever possible. One or two passages on African green monkey kidney (Vero) cells was required for mosquito-derived WNV and for lightly infected vertebrates because a reverse transcriptase-polymerase chain reaction performed directly on RNA extracts from these materials generally failed (see Table 1 for passage history information on specific WNV strains). Amplification of virus strains on Vero cells was performed as previously described.7 Additional nucleotide sequence data were obtained from GenBank.
Amplification of RNA and sequencing.
To obtain sequence data, RNA samples were reverse transcribed using specific primers. cDNA was amplified using primers designed to amplify the entire envelope region (see Ebel and others7 for primer sequences) and fragments of the nonstructural protein 5 (NS5) (608 basepairs [bp]) and 3′ nontranslated region (464 bp) (NS5F: 5′-tgaggagcgcgaggcacat-3′, NS5R: 5′-cggctgag-tctttcttccccattc-3′, 3′UTRF: 5′-cgccaccggaagttgagtagac-3′, and 3′UTRR: 5′-tcgaccaccagccaccattgt-3′). Reaction products were electrophoretically separated on a 2% agarose gel and sequenced on an ABI 3700 DNA Analyzer (Applied Biosystems, Foster City, CA). The primers used in the sequencing of the envelope region have been described elsewhere,7 and the sequences of the primers used in NS5 and 3′UTR sequencing are available from the authors upon request. Raw sequence data were assembled and edited using the SeqMan module within the DNAStar software package (DNAStar, Inc., Madison, WI). A minimum of two-fold trace redundancy was required for sequence data to be considered complete.
Phylogenetic analysis.
To reconstruct the phylogenetic relationships among the strains studied, alignments were generated using the ClustalW algorithm as implemented in DNAStar, and analyzed by the distance method using MEGA.15 Rooted trees included lineage one WNV strains from Africa and Europe. Evolutionary distances were computed using the Kimura 2-parameter method including transitions and transversions, trees were constructed using the neighbor-joining method, and their robustness was estimated by performing 1,000 bootstrap replicates. To determine the overall nucleotide and amino acid diversity within the sample of strains, the total number of substitutions within each genomic region with respect to a 1999 reference strain was divided by the total number of nucleotides sequenced in each year of observation. Statistical analyses were performed using Stata software (Stata Corporation, College Station, TX).
Mosquito transmission assays.
To determine whether genotypically defined strains may differ in in vivo phenotype in mosquitoes, we fed colonized Culex pipiens mosquitoes on selected virus strains and determined the infection, dissemination, and transmission rates of each strain at five, seven, and nine days postfeeding. Culex pipiens mosquitoes were initially collected in Albany, New York in 2001 and have been maintained in our insectary since that time (>20 generations). Virus stocks were diluted in BA1 to achieve a standard titer of 108 plaque-forming units (PFU)/0.1 mL. Two hundred fifty microliters of virus stock were then added to 5 mL of defibrinated goose blood containing 2.5% sucrose to achieve a final virus titer of 106.7 PFU/0.1 mL. Mosquitoes were allowed to feed on gauze pledgets soaked with virus-blood-sucrose mixture for two hours during which time the pledget was re-soaked once. Mosquitoes that took a full blood meal were then removed to one-pint cardboard cups and held at 27°C, a relative humidity of 85%, and 16:8 light:dark photoperiod until transmission assays were performed. At five, seven, and nine days postfeeding, mosquitoes were removed and anaesthetized with triethylamine (Sigma, St. Louis, MO). Their legs were removed to a microcentrifuge tube containing 1 mL of mosquito diluent (20% heat-inactivated fetal bovine serum [FBS] in Dulbecco’s phosphate-buffered saline plus 50 μg/mL of penicillin/streptomycin, 50 μg/mL of gentamicin, and 2.5 μg/mL of fungizone). Salivary secretions were collected in an in vitro transmission assay as described.16 Briefly, mosquito mouthparts were inserted into a capillary tube charged with a 1:1 mixture of FBS and 50% sucrose. After approximately 30 minutes, the contents of the capillary tube were discharged into 0.3 mL of mosquito diluent and the mosquito body was placed into a tube containing 1 mL of mosquito diluent. Mosquito bodies and legs were homogenized in a mixer mill (Qiagen, Inc.) at 24 cycles/second for 30 seconds and clarified by centrifugation. Mosquito bodies, legs, and salivary secretions were assayed for infection by plaque assay on Vero cells.17,18 Infection, dissemination, and transmission are defined as the proportion of exposed mosquitoes with infectious virus present in bodies, legs, and salivary secretions, respectively.
RESULTS
Virus strains representing the first four years of WNV transmission in New York and strains from previous WNV epidemics were included in this study (Table 1). Strains were collected in each year of observation from mosquito, avian, and mammalian hosts, and from throughout the state of New York. The sample of WNV strains in this study was selected to represent the population of WNV that has been actively transmitted in NY since its introduction in 1999.
Distance analysis of the envelope region of all strains in this study confirms the close relationships of WNV circulating in NY since its introduction (Figure 1). The overall tree topology is unremarkable, and the bootstrap confidence in the branching pattern is generally weak. One poorly supported cluster contained strains isolated initially during the year 2002 transmission season. In contrast, the remainder of the tree is populated by a mixture of strains isolated in each of the years surveyed. The proportion of bases sequenced and their predicted amino acids that differed from the NY99 reference sequence increased in 2002 and 2003 compared with 2000 and 2001 (Table 2). Nucleotide diversity increased approximately two-fold, and amino acid diversity increased approximately four-fold. Although WNV remained relatively homogeneous in New York during the period of observation, strains collected starting in 2002 were more distant from the strain introduced in 1999 than had been observed previously.
Unrooted neighbor-joining analyses (Figure 2) demonstrated the presence of two relatively well-supported WNV clades in New York during the period of observation: one containing strains collected during 1999–2003 (designated NY99 in Figure 2), and another containing strains collected solely during 2002 and 2003 (designated WN02 in Figure 2). These two clades were still evident when strains from the year 2002 and 2003 were considered independently, but were in-apparent in separate analyses of fragments of the NS5 and 3′ untranslated regions. Two nucleotide substitutions defined membership in this clade. One, a U to C transition at nucleotide position 1442, results in a valine to alanine substitution at position 159 of the WNV E protein. The second, a C to U transition at position 2466, is silent. Analysis of functionally diverse regions of the WNV genome showed region-specific trends of nucleotide and amino acid diversity. Protein coding regions of the WNV genome (E and NS5) had approximately two-fold more nucleotide substitutions per base sequenced than the 3′UTR, and the E coding region had approximately three-fold greater amino acid diversity than the NS5 fragment analyzed (Table 3).
In vitro growth studies in Aedes albopictus (C6/36) and African green monkey kidney (Vero) cells at multiplicities of infection of 5 and 0.05 showed little variation in viral replicative efficiency (data not shown). In vivo phenotypic analysis was conducted for two pairs of strains, each pair consisting of one member of each clade. In the first comparison (Table 4) between WNV strains 32010157 (NY99) and 02002640 (WN02), strain 02002640 more efficiently infected mosquitoes at five days postfeeding. At seven days postfeeding, strain 02002640 was again more likely to infect mosquitoes, but was also more likely to have disseminated into the hemocoel, and was more likely to be transmitted than was strain 32010157. Strain 32010157 was not transmitted by Cx. pipiens mosquitoes until nine days postfeeding: by this timepoint, the rates of infection, dissemination, and transmission were similar. In the second comparison (Table 4) between WNV strains 31000352 (NY99) and 02002831 (WN02), strain 02002831 was more likely to have disseminated by five days postfeeding, and the first transmissions occurred with this strain at five days post-feeding. At nine days postfeeding, the proportion of strains infected with strain 02002831 was lower than the proportion observed for strain 31000352. Overall, the proportion of mosquitoes that became infected and developed disseminated infections following exposure to strains of the newly recognized clade (WN02), was greater at five days postfeeding (Table 4). At seven days postfeeding, the proportions of mosquitoes infected, with a disseminated infection, and transmitting virus were also significantly higher for strains belonging to the WN02 clade than the proportions that ingested strains more closely related to NY99. Mosquito transmission assays were performed four times and similar results were obtained in each trial. These results indicate that WNV strains belonging to the WN02 clade may be more efficiently transmitted at early timepoints following mosquito acquisition of an infectious blood meal.
DISCUSSION
Strains of WNV included in this study were collected in New York State during each year since its introduction, from a wide geographic area, and from taxonomically diverse hosts. During the years 2000 and 2001, WNV was sampled from both mosquito and avian hosts to determine whether host-related differences in the envelope coding region would be apparent. When no differences were observed in sequences obtained from mosquitoes compared with sequences from birds,7 we focused our sampling in 2002 on infected birds to avoid cell culture passage of virus, which was often necessary to sequence mosquito-derived isolates. A geographic bias is apparent in the strains selected for this study, with more strains being sampled from the initial epicenter of WNV transmission in New York. This bias is a necessary consequence of WNV transmission in our sampling area: during the first three years of transmission (1999–2001), WNV was more intensely transmitted in the original epicenter than elsewhere. The sample of strains included in this study is thus an accurate representation of the virus population that has been transmitted in New York since its 1999 introduction.
The majority of the analyses focused on the WNV E coding region due to the functional significance of the flavivirus E protein in host receptor binding and membrane fusion. The E protein also contains the immunodominant epitopes responsible for neutralization and serogroup, type, and subtype definition.19 During the period of observation, only three amino acid substitutions in the E protein were detected on more than one strain examined. All three of these occurred in the central domain (Domain I) of the predicted three-dimensional structure of WNV E protein.12 The first, a V to A substitution at E159, is a conservative change that has been reported by Beasley and others,8 and is mainly buried within the protein structure. The second and third, a Y to H change at E176 and a L to Q change at E178, are less conservative and more exposed to the external environment, suggesting that immune selection may drive limited diversification of selected amino acids on the WNV E protein.
Comparative analyses of nucleotide sequences from E, NS5, and 3′UTR suggest that nucleotide substitutions may be more common in E and NS5 than in the 3′UTR, and that amino acid substitutions may be more common in E than in NS5. The relative paucity of nucleotide substitutions in the 3′UTR may indicate constraints imposed on this region by its functional significance in RNA replication.20–22 The difference observed between the proportion of substituted amino acids in E and NS5 may be due either to functional constraints (i.e., purifying selection) imposed on the NS5 protein, which codes the viral RNA-dependent RNA polymerase,23,24 or to diversifying selection imposed on the E protein due to its antigenic importance. Resolving the relative contribution of these selective forces requires further study. Both, however, have been described for flaviviruses.25–27
Phylogenetic analyses of the WNV strains sampled in this study indicate that WNV in New York remains a relatively homogeneous virus population. This finding is consistent with our previous studies of WNV in New York State7 and of WNV sampled more broadly throughout North America.8 In contrast, the proportion of bases sequenced, and their predicted amino acids, that differed from NY99 was greater in 2002 and 2003 than in 2000 or 2001, suggesting that WNV was more diverse in later than in earlier years. These findings suggest either in situ drift of WNV away from the introduced strain, or the introduction and spread of a closely related strain producing a similar effect on our analyses. The abrupt appearance of a previously unrecognized genotype in NYS in 2002 favors the latter hypothesis. The documentation of strains with this genotype in Texas,8 in addition to the now-widespread enzootic transmission of WNV in surrounding states,28 further supports the observation that an additional WNV genotype may have been introduced into New York during 2002. This genotype represents a substantial proportion (55%) of strains collected during 2002, and the majority (85%) of strains collected in 2003. Indeed, it has become dominant throughout New York State.
Phenotypic studies were conducted to assess the possibility that this newly introduced genotype may displace the existing WNV strains in New York. Selected strains representing both clades present in New York during the course of this study were included in in vitro growth and mosquito transmission experiments. Growth studies in cell culture models of WNV infection were generally uninformative: replication was essentially equivalent, with less than one log10 difference between the growth of phylogenetically defined strains at each time-point. Because cell culture systems may not be adequate models of natural transmission cycles, we then focused on an in vivo mosquito transmission model to determine whether the near complete displacement of NY99 by WN02 may be due to differences in mosquito transmission efficiency.
The term vector competence refers to the inherent ability of a particular vector mosquito to become infected with a virus (or other infectious agent) following exposure to an infectious blood meal, support viral replication, and to deliver an infectious inoculum upon taking a second blood meal. Most research on vector competence has focused on the contribution of environmental or mosquito genetic factors to vector competence.29–38 It also has been recognized that viral genotype may impact vector competence,39–42 which may lead to the displacement of one viral genotype with another.43 In the experiments reported here, viral genotype did not seem to impact overall vector competence: after nine days extrinsic incubation, similar proportions of mosquitoes infected with both genotypes were capable of transmitting WNV. However, viral genotype appears to affect the basic reproductive rate of WNV (vectorial capacity) through impacts on the extrinsic incubation period (EIP, the number of days incubation required for a mosquito to transmit an infection): WN02 reduced EIP by approximately two days, providing a possible mechanism for displacement of one viral genotype by another in the absence of an overall increase in vector competence. These findings suggest that genotype-specific increases in replicative efficiency and/or cell-to-cell spread within the mosquito host may be critical determinants of the basic reproductive rate of WNV in nature.
Interestingly, at nine days postfeeding, one strain belonging to the WN02 clade was significantly less likely to infect mosquitoes than its NY99 counterpart. This decrease may be due to either virus clearance from the mosquito or to virus-induced mosquito mortality. Additional studies are required to determine whether either of these hypotheses explains the observed differences in the proportion of infected mosquitoes.
A small number of nucleotide and/or amino acid changes may dramatically impact viral replication, virulence and host specificity. A small number of positively charged amino acid substitutions, for example, determines enzootic versus epizootic/epidemic phenotype of Venezuelan equine encephalitis virus.44 A single amino acid change in the hinge region of the flavivirus envelope region impacts neuroinvasion in mice and viscerotropism in primates.45 The single amino acid change (E159) that defines the newly introduced genotype seems unlikely to be the determinant of altered EIP phenotype due to its conservative and unexposed nature. However, sequencing of the complete genomes of all strains used in mosquito transmission studies (Ebel GD and others, unpublished data) has failed to identify any other amino acid substitutions that WN02 strains have in common. Additional studies using reverse genetics systems are required to determine whether the V to A substitution at E159 may impact mosquito transmission of WNV.
We observed a dramatic increase in the intensity of WNV transmission in New York beginning in 2002 compared with previous years. Non-viral determinants are well known to impact arbovirus transmission and epidemiology,46–50 and it is highly likely that some of these contributed to the observed increase in cases of human disease. However, the observations reported here establish that this increase was accompanied by an increase in genetic diversity that was largely mediated by the introduction of a previously unrecognized WNV genotype during 2002. Studies are in progress to further assess the role of viral genotype in the WNV EIP, to define the molecular determinants of this phenotype, and to assess whether this newly recognized clade may be in the process of displacing the WNV clade that existed in New York State prior to 2002.
West Nile virus strains included in the study
Accession no.‡ | |||||||||
---|---|---|---|---|---|---|---|---|---|
ID* | Strain | Passage history† | Source | New York county | Clade | Env | NS5 | 3′UTR | Reference |
* ID designations used in phylogenetic trees. The first two digits of the ID refer to the year in which the strain was collected (e.g., 03n was collected in 2003, 00a was collected in 2000, etc.). | |||||||||
† V1 = virus isolate following one vero cell passage; V2 = virus isolate following two vero cell passages; P = primary tissue RNA extract. | |||||||||
‡ Env = envelope; NS = nonstructural; UTR = untranslated region; NA = not applicable. | |||||||||
§ Strains used in mosquito transmission experiments. | |||||||||
NY99 | NY99 EQHS | V1 | Horse | Suffolk | NY99 | af260967 | af260967 | af260967 | 13 |
00a | 3000017 | V2 | Culex pipiens (CP) | Richmond | NY99 | af346309 | NA | NA | 7 |
00b | 3000259 | V2 | CP/Cx. restuans (PRE) | Suffolk | NY99 | af346316 | NA | NA | 7 |
00c | 3000548 | V2 | PRE | Queens | NY99 | af346311 | NA | NA | 7 |
00d | 3000622 | V2 | PRE | Westchester | NY99 | af346313 | NA | NA | 7 |
00e | 3100271 | V2 | PRE | Rockland | NY99 | af346312 | NA | NA | 7 |
00f | 3100352§ | V2 | Cx. salinarius | Richmond | NY99 | af346314 | NA | NA | 7 |
00g | 3100365 | V2 | CP | Richmond | NY99 | af346310 | NA | NA | 7 |
00h | 842 | V2 | American crow (AC) | Richmond | NY99 | af346317 | NA | NA | 7 |
00i | 2741 | V2 | AC | Albany | NY99 | af346315 | NA | NA | 7 |
00j | 3282 | P | Ruffed grouse | Oswego | NY99 | af346319 | NA | NA | 7 |
00k | 3356 | P | AC | Richmond | NY99 | af346318 | NA | NA | 7 |
01a | 01000431 | P | AC | Westchester | NY99 | ay369403 | NA | NA | This paper (A) |
01b | 01000658 | P | AC | Rockland | NY99 | ay369404 | NA | NA | 7 |
01c | 01001398 | P | AC | Suffolk | NY99 | ay369405 | NA | NA | A |
01d | 01001399 | P | Blue jay | Richmond | NY99 | ay369406 | NA | NA | A |
01e | 01001779 | P | AC | Nassau | NY99 | ay369407 | NA | NA | A |
01f | 01002053 | P | AC | Suffolk | NY99 | ay369408 | NA | NA | A |
01g | 01002363 | P | House sparrow | Richmond | NY99 | ay369409 | NA | NA | A |
01h | 01002394 | P | Blue jay | Westchester | NY99 | ay369410 | NA | NA | A |
01i | 33010257 | V1 | PRE | Nassau | NY99 | ay369411 | NA | NA | A |
01j | 32010157§ | V1 | PRE | Suffolk | NY99 | ay369412 | NA | NA | A |
01k | NYC01006 | V1 | PRE | Richmond | NY99 | ay369413 | NA | NA | A |
01l | NYC01035 | V1 | PRE | Richmond | NY99 | ay369415 | NA | NA | A |
01m | NYC01038 | V1 | PRE | Richmond | NY99 | ay369414 | NA | NA | A |
02a | 02003555 | P | AC | Onondaga | WN02 | ay369416 | NA | NA | A |
02b | 34020055 | V2 | PRE | Nassau | WN02 | ay369417 | NA | NA | A |
02c | 007365 | V2 | Horse | Schenectady | WN02 | ay369418 | NA | NA | A |
02d | 02003688 | V2 | Gray squirrel | Schenectady | WN02 | ay369419 | ay369453 | ay369401 | A |
02e | 6302 | P | Human | Nassau | NY99 | af533540 | af533540 | af533540 | 51 |
02f | 02002395 | P | AC | Niagara | WN02 | ay369420 | ay369438 | ay369386 | A |
02g | 02002640§ | P | AC | Niagara | WN02 | ay369421 | ay369440 | ay369388 | A |
02h | 02002831§ | P | AC | Broome | WN02 | ay369422 | ay369446 | ay369394 | A |
02i | 02003204 | P | AC | Albany | WN02 | ay369428 | ay369449 | ay369397 | A |
02j | 02002684 | P | AC | Clinton | NY99 | ay369423 | ay369442 | ay369390 | A |
02k | 02002681 | P | AC | Nassau | NY99 | ay369424 | ay369441 | ay369389 | A |
02l | 02002554 | P | AC | Manhattan | NY99 | ay369425 | ay369439 | ay369387 | A |
02m | 02003654 | P | AC | Suffolk | NY99 | ay369429 | ay369452 | ay369400 | A |
02n | 02003557 | P | AC | Broome | NY99 | ay369435 | ay369451 | ay369399 | A |
02o | 02002306 | P | AC | Richmond | NY99 | ay369430 | ay369437 | ay369385 | A |
02p | 02003535 | P | AC | Kings | NY99 | ay369426 | ay369450 | ay369398 | A |
02q | 02002735 | P | AC | Rockland | WN02 | ay369427 | ay369443 | ay369391 | A |
02r | 02003944 | P | AC | Queens | WN02 | ay369431 | ay369454 | ay369402 | A |
02s | 02002868 | P | AC | Bronx | NY99 | ay369432 | ay369447 | ay369395 | A |
02t | 02003011 | P | AC | Queens | WN02 | ay369433 | ay369448 | ay369396 | A |
02u | 02002771 | P | AC | Richmond | NY99 | ay369434 | ay369445 | ay369393 | A |
02v | 02002758 | P | AC | Clinton | WN02 | ay369436 | ay369444 | ay369392 | A |
03a | 03000360 | P | AC | Westchester | NY99 | ay590229 | ay590249 | ay590191 | A |
03b | 03001087 | P | AC | Erie | NY99 | ay590211 | ay590231 | ay590192 | A |
03c | 03001426 | P | AC | St. Lawrence | WN02 | ay590212 | ay590232 | ay590193 | A |
03d | 03001516 | P | AC | Broome | WN02 | ay590213 | ay590233 | ay590194 | A |
03e | 03001543 | P | AC | Monroe | WN02 | ay590214 | ay590234 | ay590195 | A |
03f | 03001619 | P | AC | Putnam | WN02 | ay590215 | ay590235 | ay590196 | A |
03g | 03001700 | P | AC | Onondaga | WN02 | ay590216 | ay590236 | ay590197 | A |
03h | 03001721 | P | AC | Queens | WN02 | ay590217 | ay590237 | ay590198 | A |
03i | 03001734 | P | AC | Richmond | WN02 | ay590218 | ay590238 | ay590199 | A |
03j | 03001816 | P | AC | Nassau | WN02 | ay590219 | ay590239 | ay590200 | A |
03k | 03001869 | P | AC | Bronx | WN02 | ay590220 | ay590240 | ay590201 | A |
03l | 03001895 | P | AC | Columbia | WN02 | ay590221 | ay590241 | ay590202 | A |
03m | 03001956 | P | AC | New York | WN02 | ay590222 | ay590242 | ay590203 | A |
03n | 03001986 | P | AC | Albany | WN02 | ay590223 | ay590243 | ay590204 | A |
03o | 03002018 | P | AC | Suffolk | WN02 | ay590224 | ay590244 | ay590205 | A |
03p | 03002031 | P | AC | Kings | WN02 | ay590225 | ay590245 | ay590206 | A |
03q | 03002035 | P | AC | Saratoga | WN02 | ay590226 | ay590246 | ay590207 | A |
03r | 03002066 | P | AC | Niagara | WN02 | ay590227 | ay590247 | ay590208 | A |
03s | 03002086 | P | AC | Chautauqua | WN02 | ay590228 | ay590248 | ay590209 | A |
03t | 03002094 | P | AC | Rockland | NY99 | ay590210 | ay590230 | ay590190 | A |
Proportion of bases and predicted amino acids of the West Nile virus envelope coding region that differ from strain NY99
Nucleotides | Predicted amino acids | ||||||
---|---|---|---|---|---|---|---|
Year | No. of strains | No. of substitutions | No. sequenced | Proportion substituted* | No. of substitutions | No. sequenced | Proportion substituted* |
* P < 0.01 by Fisher’s exact test. | |||||||
2000 | 11 | 14 | 16,533 | 10−3.07 | 2 | 5,511 | 10−3.44 |
2001 | 13 | 16 | 19,539 | 10−3.09 | 3 | 6,517 | 10−3.34 |
2002 | 22 | 55 | 33,066 | 10−2.78 | 18 | 11,022 | 10−2.79 |
2003 | 20 | 63 | 30,060 | 10−2.68 | 22 | 10,020 | 10−2.66 |
Proportion of nucleotides and predicted amino acids that differ from West Nile virus strain NY99 by genome region*
Nucleotides | Predicted amino acids | ||||||
---|---|---|---|---|---|---|---|
Region | Length of fragment (nucleotides) | No. of substitutions | No. sequenced | Proportion substituted† | No. of substitutions | No. sequenced | Proportion substituted† |
* E = envelope; NS = nonstructural; UTR = untranslated region; NA = not applicable. | |||||||
† P < 0.01 by Fisher’s exact test. | |||||||
E | 1503 | 109 | 58,617 | 10−2.73 | 36 | 19,539 | 10−2.73 |
NS5 | 608 | 57 | 23,712 | 10−2.62 | 4 | 7,878 | 10−3.29 |
3′UTR | 464 | 19 | 18,096 | 10−2.98 | NA | NA | NA |
Impact of West Nile virus genotype on mosquito transmission phenotype
Days postfeeding | |||||||||
---|---|---|---|---|---|---|---|---|---|
5 | 7 | 9 | |||||||
Percent | Percent | Percent | |||||||
Strain | Infected | Disseminated | Transmitted | Infected | Disseminated | Transmitted | Infected | Disseminated | Transmitted |
* Cumulative totals from four trials. | |||||||||
† Determined by chi-square test. | |||||||||
32010157* (NY99) | 27 (n = 75) | 4 | 0 | 32 (n = 123) | 5 | 0 | 40 (n = 84) | 10 | 5 |
02002640* (WN02) | 51 (n = 73) | 5 | 0 | 47 (n = 92) | 15 | 5 | 38 (n = 68) | 13 | 4 |
P† | 0.004 | 0.717 | 1.000 | 0.033 | 0.016 | 0.013 | 0.868 | 0.606 | 1.000 |
31000352* (NY99) | 28 (n = 112) | 4 | 0 | 33 (n = 92) | 12 | 4 | 29 (n = 49) | 14 | 4 |
02002831* (WN02) | 28 (n = 102) | 15 | 3 | 38 (n = 98) | 13 | 6 | 12 (n = 51) | 10 | 6 |
P† | 0.903 | 0.010 | 0.068 | 0.458 | 0.768 | 0.584 | 0.036 | 0.491 | 0.680 |
Total NY99 | 27 (n = 187) | 4 | 0 | 32 (n = 215) | 8 | 2 | 36 (n = 133) | 11 | 5 |
Total WN02 | 3 (n = 175) | 11 | 2 | 42 (n = 190) | 14 | 6 | 27 (n = 119) | 12 | 5 |
P† | 0.034 | 0.017 | 0.072 | 0.037 | 0.042 | 0.037 | 0.117 | 0.904 | 0.843 |

Distance analysis of the West Nile virus envelope glycoprotein coding region. Numbers at nodes indicate bootstrap confidence based on 1,000 replicates. GenBank accession numbers are provided in Table 1, except for ITequine98 (Italian isolate -af404757), ROpipiens96 (Romanian isolate - af260969), VOhuman99 (Russian isolate - af317203), and Eg101 (Egyptian isolate - af260969).
Citation: The American Journal of Tropical Medicine and Hygiene Am J Trop Med Hyg 71, 4; 10.4269/ajtmh.2004.71.493

Distance analysis of the West Nile virus envelope glycoprotein coding region. Numbers at nodes indicate bootstrap confidence based on 1,000 replicates. GenBank accession numbers are provided in Table 1, except for ITequine98 (Italian isolate -af404757), ROpipiens96 (Romanian isolate - af260969), VOhuman99 (Russian isolate - af317203), and Eg101 (Egyptian isolate - af260969).
Citation: The American Journal of Tropical Medicine and Hygiene Am J Trop Med Hyg 71, 4; 10.4269/ajtmh.2004.71.493
Distance analysis of the West Nile virus envelope glycoprotein coding region. Numbers at nodes indicate bootstrap confidence based on 1,000 replicates. GenBank accession numbers are provided in Table 1, except for ITequine98 (Italian isolate -af404757), ROpipiens96 (Romanian isolate - af260969), VOhuman99 (Russian isolate - af317203), and Eg101 (Egyptian isolate - af260969).
Citation: The American Journal of Tropical Medicine and Hygiene Am J Trop Med Hyg 71, 4; 10.4269/ajtmh.2004.71.493

Unrooted distance analysis of the West Nile virus envelope glycoprotein coding region. Numbers at nodes indicate bootstrap confidence levels. Only values greater than 50 are shown.
Citation: The American Journal of Tropical Medicine and Hygiene Am J Trop Med Hyg 71, 4; 10.4269/ajtmh.2004.71.493

Unrooted distance analysis of the West Nile virus envelope glycoprotein coding region. Numbers at nodes indicate bootstrap confidence levels. Only values greater than 50 are shown.
Citation: The American Journal of Tropical Medicine and Hygiene Am J Trop Med Hyg 71, 4; 10.4269/ajtmh.2004.71.493
Unrooted distance analysis of the West Nile virus envelope glycoprotein coding region. Numbers at nodes indicate bootstrap confidence levels. Only values greater than 50 are shown.
Citation: The American Journal of Tropical Medicine and Hygiene Am J Trop Med Hyg 71, 4; 10.4269/ajtmh.2004.71.493
Authors’ addresses: Gregory D. Ebel, Kristen A. Bernard, and Laura D. Kramer, Arbovirus Laboratories, Wadsworth Center, New York State Department of Health, 5668 State Farm Road, Slingerlands, NY 12159 and Department of Biomedical Sciences, The University at Albany, State University of New York, Albany, NY 12208, Telephone: 518-852-5295, Fax: 518-869-4530, E-mail: ebel@wadsworth.org. Justin Carricaburu and David Young, Arbovirus Laboratories, Wadsworth Center, New York State Department of Health, 5668 State Farm Road, Slingerlands, NY 12159.
Acknowledgments: We thank Ilia Rochlin, Sarah Macinski, and Jennifer Longacker for generous entomologic assistance, Eric and Lauren Biesbroeck for technical assistance, Elizabeth Kauffman, Mary Franke, and Susan Jones for additional technical support, Jan Conn for suggestions regarding the manuscript, the New York State Department of Health’s Division of Epidemiology for supervising collection of specimens, and the Wadsworth Center Molecular Genetics Core facility for performing sequencing.
Financial support: This work was supported by National Institutes of Health grant N01 AI-25490.
REFERENCES
- 1↑
Anonymous, 1999. From the Centers for Disease Control and Prevention. Update: West Nile virus encephalitis-New York, 1999. JAMA 282 :1806–1807.
- 2↑
Bernard KA, Maffei J, Jones SA, Kauffman EB, Ebel GD, Dupuis AP, Ngo K, Nicholas D, Young D, Shi PY, Eidson M, White DJ, Stone W, Kramer LD, 2001. Comparison of West Nile virus infection in birds and mosquitoes in New York State in 2000. Emerg Infect Dis 7 :679–685.
- 3↑
Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, Vande-Pol S, 1982. Rapid evolution of RNA genomes. Science 215 :1577–1585.
- 4↑
Kuno G, Chang GJ, Tsuchiya KR, Karabatsos N, Cropp CB, 1998. Phylogeny of the genus Flavivirus. J Virol 72 :73–83.
- 5
Lanciotti RS, Gubler DJ, Trent DW, 1997. Molecular evolution and phylogeny of dengue-4 viruses. J Gen Virol 78 :2279–2284.
- 6↑
Weaver SC, Hagenbaugh A, Bellew LA, Gousset L, Mallampalli V, Holland JJ, Scott TW, 1994. Evolution of alphaviruses in the eastern equine encephalomyelitis complex. J Virol 68 :158–169.
- 7↑
Ebel GD, Dupuis AP, Ngo K, Nicholas D, Kauffman EB, Jones SA, Young D, Maffei J, Shi PY, Bernard KA, Kramer LD, 2001. Partial genetic characterization of WNV strains isolated in New York State during the 2000 transmission season. Emerg Infect Dis 7 :650–653.
- 8↑
Beasley DW, Davis CT, Guzman H, Vanlandingham DL, Travassos da Rosa AP, Parsons RE, Higgs S, Tesh RB, Barrett AD, 2003. Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States. Virology 309 :190–195.
- 9↑
Allison SL, Schalich J, Stiasny K, Mandl CW, Heinz FX, 2001. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol 75 :4268–4275.
- 10
Holzmann H, Stiasny K, York H, Dorner F, Kunz C, Heinz FX, 1995. Tick-borne encephalitis virus envelope protein E-specific monoclonal antibodies for the study of low pH-induced conformational changes and immature virions. Arch Virol 140 :213–221.
- 11
Mandl CW, Allison SL, Holzmann H, Meixner T, Heinz FX, 2000. Attenuation of tick-borne encephalitis virus by structure-based site- specific mutagenesis of a putative flavivirus receptor binding site. J Virol 74 :9601–9609.
- 12↑
Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC, 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375 :291–298.
- 13↑
Lanciotti RS, Ebel GD, Deubel V, Kerst AJ, Murri S, Meyer R, Bowen M, McKinney N, Morrill WE, Crabtree MB, Kramer LD, Roehrig JT, 2002. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 298 :96–105.
- 14↑
Kauffman EB, Jones SA, Dupuis AP, Ngo K, Bernard KA, Kramer LD, 2003. Virus detection protocols for West Nile virus in vertebrate and mosquito specimens. J Clin Microbiol 41 :3661–3667.
- 15↑
Kumar S, Tamura K, Nei M, 1993. MEGA: Molecular Evolutionary Genetics Analysis. University Park, PA: Pennsylvania State University.
- 16↑
Aitken THG, 1977. An in vitro feeding technique for artificially demonstrating virus transmission by mosquitoes. Mosq News 37 :130–133.
- 17↑
Ebel GD, Dupuis AP, Nicholas D, Young D, Maffei J, Kramer LD, 2002. Detection by enzyme-linked immunosorbent assay of antibodies to West Nile virus in birds. Emerg Infect Dis 8 :979–982.
- 18↑
Lindsey HS, Calisher CH, Matthews JH, 1976. Serum dilution neutralization test for California group virus identification and serology. J Clin Microbiol 4 :503–510.
- 19↑
Roehrig JT, Heinz FX, 1990. Flaviviruses. van Regen Mortel MHV, Neurath AR, eds. Immunochemistry of Viruses II, the Basis for Serodiagnosis and Vaccines. New York: Elsevier, 289–305.
- 20↑
You S, Falgout B, Markoff L, Padmanabhan R, 2001. In vitro RNA synthesis from exogenous dengue viral RNA templates requires long range interactions between 5′- and 3′-terminal regions that influence RNA structure. J Biol Chem 276 :15581–15591.
- 21
Blackwell JL, Brinton MA, 1995. BHK cell proteins that bind to the 3′ stem-loop structure of the West Nile virus genome RNA. J Virol 69 :5650–5658.
- 22↑
Hahn CS, Hahn YS, Rice CM, Lee E, Dalgarno L, Strauss EG, Strauss JH, 1987. Conserved elements in the 3′ untranslated region of flavivirus RNAs and potential cyclization sequences. J Mol Biol 198 :33–41.
- 23↑
Khromykh AA, Sedlak PL, Westaway EG, 2000. cis- and transacting elements in flavivirus RNA replication. J Virol 74 :3253–3263.
- 24↑
Steffens S, Thiel HJ, Behrens SE, 1999. The RNA-dependent RNA polymerases of different members of the family Flaviviridae exhibit similar properties in vitro. J Gen Virol 80 :2583–2590.
- 25↑
Twiddy SS, Farrar JJ, Vinh CN, Wills B, Gould EA, Gritsun T, Lloyd G, Holmes EC, 2002. Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus. Virology 298 :63–72.
- 26
Twiddy SS, Woelk CH, Holmes EC, 2002. Phylogenetic evidence for adaptive evolution of dengue viruses in nature. J Gen Virol 83 :1679–1689.
- 27↑
Ebel GD, Spielman A, Telford SR III, 2001. Phylogeny of North American Powassan virus. J Gen Virol 82 :1657–1665.
- 28↑
Anon., 2002. Provisional surveillance summary of the West Nile virus epidemic-United States, January–November 2002. MMWR Morb Mortal Wkly Rep 51 :1129–1133.
- 29↑
Bosio CF, Beaty BJ, Black WC, 1998. Quantitative genetics of vector competence for dengue-2 virus in Aedes aegypti. Am J Trop Med Hyg 59 :965–970.
- 30
Bosio CF, Fulton RE, Salasek ML, Beaty BJ, Black WC, 2000. Quantitative trait loci that control vector competence for dengue-2 virus in the mosquito Aedes aegypti. Genetics 156 :687–698.
- 31
Ahmed T, Hayes CG, Baqar S, 1979. Comparison of vector competence for West Nile virus of colonized populations of Culex tritaeniorhynchus from southern Asia and the Far East. Southeast Asian J Trop Med Public Health. 10 :498–504.
- 32
Boromisa RD, Rai KS, Grimstad PR, 1987. Variation in the vector competence of geographic strains of Aedes albopictus for dengue 1 virus. J Am Mosq Control Assoc. 3 :378–386.
- 33
Hardy JL, Houk EJ, Kramer LD, Reeves WC, 1983. Intrinsic factors affecting vector competence of mosquitoes for arboviruses. Annu Rev Entomol 28 :229–262.
- 34
Reisen WK, Hardy JL, Presser SB, 1997. Effects of water quality on the vector competence of Culex tarsalis (Diptera: Culicidae) for western equine encephalomyelitis (Togaviridae) and St. Louis encephalitis (Flaviviridae) viruses. J Med Entomol 34 :631–643.
- 35
Reisen WK, Hardy JL, Presser SB, Chiles RE, 1996. Seasonal variation in the vector competence of Culex tarsalis (Diptera: Culicidae) from the Coachella Valley of California for western equine encephalomyelitis and St. Louis encephalitis viruses. J Med Entomol 33 :433–437.
- 36
Reisen WK, Reeves WC, Hardy J, Milby MM, 1991. Effects of climatological change on the population dynamics and vector competence of mosquito vectors in California. Proc Calif Mosq Vector Conrtol Assoc 59 :14–20.
- 37
Turell MJ, 1989. Effect of environmental temperature on the vector competence of Aedes fowleri for Rift Valley fever virus. Res Virol 140 :147–154.
- 38↑
Turell MJ, Rossi CA, Bailey CL, 1985. Effect of extrinsic incubation temperature on the ability of Aedes taeniorhynchus and Culex pipiens to transmit Rift Valley fever virus. Am J Trop Med Hyg 34 :1211–1218.
- 39↑
Hardy JL, Presser SB, Meyer RP, Reisen WK, Kramer LD, Vorndam AV, 1986. Comparison of a 1984 Los Angeles strain of SLE virus with earlier California strains of SLE virus: mouse virulence, chicken viremogenic, RNA oligonucleotide and vector competence characteristics. Proc Calif Mosq Vector Control Assoc 53 :10–15.
- 40
Armstrong PM, Rico-Hesse R, 2001. Differential susceptibility of Aedes aegypti to infection by the American and Southeast Asian genotypes of dengue type 2 virus. Vector Borne Zoonotic Dis 1 :159–168.
- 41
Brault AC, Powers AM, Weaver SC, 2002. Vector infection determinants of Venezuelan equine encephalitis virus reside within the E2 envelope glycoprotein. J Virol 76 :6387–6392.
- 42↑
Armstrong PM, Rico-Hesse R, 2003. Efficiency of dengue sero-type 2 virus strains to infect and disseminate in Aedes aegypti. Am J Trop Med Hyg 68 :539–544.
- 43↑
Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C, Boshell J, de Mesa MT, Nogueira RM, da Rosa AT, 1997. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230 :244–251.
- 44↑
Brault AC, Powers AM, Holmes EC, Woelk CH, Weaver SC, 2002. Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of Venezuelan equine encephalitis virus. J Virol 76 :1718–1730.
- 45↑
Monath TP, Arroyo J, Levenbook I, Zhang ZX, Catalan J, Draper K, Guirakhoo F, 2002. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J Virol 76 :1932–1943.
- 46↑
Reiter P, 1988. Weather, vector biology, and arboviral recrudescence. Monath, TP ed. The Arboviruses: Epidemiology and Ecology. Boca Raton, FL: CRC Press, 245–255.
- 47
Lothrop HD, Reisen WK, 2001. Landscape affects the host-seeking patterns of Culex tarsalis (Diptera: Culicidae) in the Coachella Valley of California. J Med Entomol 38 :325–332.
- 48
Meyer RP, Hardy JL, Reisen WK, 1990. Diel changes in adult mosquito microhabitat temperatures and their relationship to the extrinsic incubation of arboviruses in mosquitoes in Kern County, California. J Med Entomol 27 :607–614.
- 49
Reeves WC, Hardy JL, Reisen WK, Milby MM, 1994. Potential effect of global warming on mosquito-borne arboviruses. J Med Entomol 31 :323–332.
- 50↑
Reisen WK, Lothrop HD, Presser SB, Milby MM, Hardy JL, Wargo MJ, Emmons RW, 1995. Landscape ecology of arboviruses in southern California: temporal and spatial patterns of vector and virus activity in Coachella Valley, 1990–1992. J Med Entomol 32 :255–266.
- 51
Huang C, Slater B, Rudd R, Parchuri N, Hull R, Dupuis M, Hindenburg A, 2002. First isolation of West Nile virus from a patient with encephalitis in the United States. Emerg Infect Dis 8 :1367–1371.